Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20031
20052
20061
20085
20095
20102
20116
20123
20134
20143
20157
20166
20176
20187
20192
20209
20216
20229
20237
202410
20256
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Terminated23
Recruiting22
Unknown status8
Withdrawn7
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanta University7
Applied Molecular Transport3
AstraZeneca3
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)3
Amgen2
Charite University, Berlin, Germany2
Eli Lilly and Company2
Lakefront Biotherapeutics NV2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
Milton S. Hershey Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases121
Colitis, Ulcerative55
Crohn Disease44
Colitis11
Gastrointestinal Diseases7
Digestive System Diseases6
Cholangitis, Sclerosing4
Intestinal Diseases4
Arthritis, Rheumatoid3
Diarrhea3

Trials

Showing 26 to 50 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.